GRAG vs. CRCA
GRAG (Leverage Shares 2X Long GRAB Daily ETF) and CRCA (ProShares Ultra CRCL) are both Leveraged Equities funds. Both are actively managed. At a 0.17 correlation, their price movements are largely independent. GRAG charges 0.75%/yr vs 0.95%/yr for CRCA.
Performance
GRAG vs. CRCA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GRAG achieves a -56.61% return, which is significantly lower than CRCA's -44.22% return.
GRAG
- 1D
- -4.47%
- 1M
- -2.43%
- YTD
- -56.61%
- 6M
- -60.13%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CRCA
- 1D
- -0.84%
- 1M
- -54.05%
- YTD
- -44.22%
- 6M
- -53.96%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GRAG vs. CRCA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
GRAG Leverage Shares 2X Long GRAB Daily ETF | -56.61% | -5.79% |
CRCA ProShares Ultra CRCL | -44.22% | -22.66% |
Correlation
The correlation between GRAG and CRCA is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Dec 11, 2025 | 0.17 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GRAG vs. CRCA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Leverage Shares 2X Long GRAB Daily ETF (GRAG) and ProShares Ultra CRCL (CRCA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Drawdowns
GRAG vs. CRCA - Drawdown Comparison
The maximum GRAG drawdown since its inception was -65.33%, smaller than the maximum CRCA drawdown of -94.31%. Use the drawdown chart below to compare losses from any high point for GRAG and CRCA.
Loading charts...
Drawdown Indicators
| GRAG | CRCA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -65.33% | -94.31% | +28.98% |
Current DrawdownCurrent decline from peak | -60.91% | -91.45% | +30.54% |
Average DrawdownAverage peak-to-trough decline | -41.46% | -71.64% | +30.18% |
Volatility
GRAG vs. CRCA - Volatility Comparison
Loading charts...
Volatility by Period
| GRAG | CRCA | Difference | |
|---|---|---|---|
Volatility (1Y)Calculated over the trailing 1-year period | 70.21% | 194.81% | -124.60% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 70.21% | 194.81% | -124.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 70.21% | 194.81% | -124.60% |
GRAG vs. CRCA - Expense Ratio Comparison
GRAG has a 0.75% expense ratio, which is lower than CRCA's 0.95% expense ratio.
Dividends
GRAG vs. CRCA - Dividend Comparison
GRAG has not paid dividends to shareholders, while CRCA's dividend yield for the trailing twelve months is around 3.11%.
| Position | TTM | 2025 |
|---|---|---|
CRCA ProShares Ultra CRCL | 3.11% | 1.06% |
GRAG Leverage Shares 2X Long GRAB Daily ETF | 0.00% | 0.00% |
Frequently Asked Questions
GRAG and CRCA have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, GRAG is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.
GRAG is cheaper with a 0.75% expense ratio, compared with 0.95% for CRCA.
CRCA has the higher dividend yield at 3.11%, compared with 0.00% for GRAG.
They also come from different issuers: Leverage Shares and ProShares. Their fees differ too: 0.75% for GRAG and 0.95% for CRCA.
Find the right allocation for GRAG and CRCA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer